GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,996,404 | -18.4% | 1,547,600 | +0.6% | 0.01% | -14.3% |
| Q3 2022 | $2,446,000 | -26.1% | 1,538,348 | -17.7% | 0.01% | -22.2% |
| Q2 2022 | $3,308,000 | -84.5% | 1,868,896 | -63.6% | 0.01% | -81.2% |
| Q1 2022 | $21,282,000 | +92.0% | 5,128,300 | +17.5% | 0.05% | +128.6% |
| Q4 2021 | $11,083,000 | -39.7% | 4,363,315 | -6.9% | 0.02% | -40.0% |
| Q3 2021 | $18,371,000 | -38.8% | 4,686,565 | 0.0% | 0.04% | -37.5% |
| Q2 2021 | $30,041,000 | -20.8% | 4,686,565 | 0.0% | 0.06% | -24.3% |
| Q1 2021 | $37,914,000 | -10.6% | 4,686,565 | -7.2% | 0.07% | -14.9% |
| Q4 2020 | $42,391,000 | +474.6% | 5,052,523 | +184.2% | 0.09% | +411.8% |
| Q3 2020 | $7,378,000 | -9.2% | 1,777,777 | 0.0% | 0.02% | -15.0% |
| Q2 2020 | $8,124,000 | – | 1,777,777 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |